115 related articles for article (PubMed ID: 12883474)
21. Phosphorylation of pRb is required for HGF-induced muscle cell proliferation and is p27kip1-dependent.
Leshem Y; Halevy O
J Cell Physiol; 2002 May; 191(2):173-82. PubMed ID: 12064460
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
23. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
24. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.
Lim MS; Adamson A; Lin Z; Perez-Ordonez B; Jordan RC; Tripp S; Perkins SL; Elenitoba-Johnson KS
Blood; 2002 Oct; 100(8):2950-6. PubMed ID: 12351407
[TBL] [Abstract][Full Text] [Related]
25. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
26. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.
Kitajima S; Kudo Y; Ogawa I; Bashir T; Kitagawa M; Miyauchi M; Pagano M; Takata T
Am J Pathol; 2004 Dec; 165(6):2147-55. PubMed ID: 15579456
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
Lu Y; Zi X; Pollak M
Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
[TBL] [Abstract][Full Text] [Related]
28. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2.
Rodier G; Makris C; Coulombe P; Scime A; Nakayama K; Nakayama KI; Meloche S
J Cell Biol; 2005 Jan; 168(1):55-66. PubMed ID: 15631990
[TBL] [Abstract][Full Text] [Related]
29. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
[TBL] [Abstract][Full Text] [Related]
30. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation.
Sarmento LM; Huang H; Limon A; Gordon W; Fernandes J; Tavares MJ; Miele L; Cardoso AA; Classon M; Carlesso N
J Exp Med; 2005 Jul; 202(1):157-68. PubMed ID: 15998794
[TBL] [Abstract][Full Text] [Related]
31. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
32. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase.
Chiarle R; Fan Y; Piva R; Boggino H; Skolnik J; Novero D; Palestro G; De Wolf-Peeters C; Chilosi M; Pagano M; Inghirami G
Am J Pathol; 2002 Apr; 160(4):1457-66. PubMed ID: 11943729
[TBL] [Abstract][Full Text] [Related]
33. High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2.
Tsukada Y; Miyazawa K; Kitamura N
J Biol Chem; 2001 Nov; 276(44):40968-76. PubMed ID: 11533045
[TBL] [Abstract][Full Text] [Related]
34. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
[TBL] [Abstract][Full Text] [Related]
35. [Effect of Skp2 antisense oligodeoxynucleotide on growth and proliferation of K562 cells].
Wang XZ; Feng WL; Liu X; Cao WX; Huang ZG
Ai Zheng; 2003 Sep; 22(9):948-53. PubMed ID: 12969527
[TBL] [Abstract][Full Text] [Related]
36. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
37. Recovery of liver mass without proliferation of hepatocytes after partial hepatectomy in Skp2-deficient mice.
Minamishima YA; Nakayama K; Nakayama K
Cancer Res; 2002 Feb; 62(4):995-9. PubMed ID: 11861371
[TBL] [Abstract][Full Text] [Related]
38. Skp2-mediated degradation of p27 regulates progression into mitosis.
Nakayama K; Nagahama H; Minamishima YA; Miyake S; Ishida N; Hatakeyama S; Kitagawa M; Iemura S; Natsume T; Nakayama KI
Dev Cell; 2004 May; 6(5):661-72. PubMed ID: 15130491
[TBL] [Abstract][Full Text] [Related]
39. Induction of p21 and p27 expression by amino acid deprivation of HepG2 human hepatoma cells involves mRNA stabilization.
Leung-Pineda V; Pan Y; Chen H; Kilberg MS
Biochem J; 2004 Apr; 379(Pt 1):79-88. PubMed ID: 14715082
[TBL] [Abstract][Full Text] [Related]
40. Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor.
Shima N; Stolz DB; Miyazaki M; Gohda E; Higashio K; Michalopoulos GK
J Cell Physiol; 1998 Oct; 177(1):130-6. PubMed ID: 9731753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]